Actinogen Medical targets Alzheimer’s treatment gap in projected $20BN market
Recce Pharmaceuticals advances R327 as diabetes and antibiotic resistance burdens converge
A new valve, a new playbook: How Anteris is trying to reshape a $10B heart market
Only registered members can use this feature.
or
Copyright © Proactive Group Holdings Inc, 2026
All Rights Reserved - Proactive Australia PTY LTD ACN:132787654 ABN:19132787654.
Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use.